Skip to content
SpinSpin

The Zimbabwean Government Turns Down ‘Unbalanced’ US Healthcare Assistance Agreement Due to Data Concerns

Medical aid illustration
The proposed US financial assistance was aimed at programmes for HIV/Aids treatment and prevention, TB, and malaria.

Zimbabwe has turned down a major American health deal worth $367m (272 million pounds) over five years over the United States' insistence on confidential biological samples.

This move was revealed after a internal memorandum dated December was leaked, which showed Head of State Emmerson Mnangagwa believed the deal was "skewed".

An official spokesman has since clarified that the US was seeking health data for scientific study and commercial purposes while was unwilling to guarantee the benefits from any future vaccines.

"We are forced to start the difficult and regrettable task of ending our support in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont publicly.

The US Embassy said the US had provided over $1.9bn in health funding to Zimbabwe over the last two decades.

A physicians' group in Zimbabwe has appealed for more negotiations to secure a agreement acceptable to both sides so the country's vital HIV treatment initiative can continue.

Wider Implications

This rejection follows a similar case in neighbouring Kenya, where a high court blocked a similar deal with the US after legal challenges were filed about the security of Kenyans' medical information.

Since resuming office recently, US President Donald Trump has reduced overseas assistance and closed the US Agency for International Development (USAID).

The agency had overseen aid for the US government, but Trump claimed its spending was "wasteful" and his administration was pursuing government-to-government deals to boost transparency and accountability.

Based on reports, 16 African countries have to date signed these new agreements, representing more than $18.3bn in new funding.

Details of the Rejected Deal

This assistance for Zimbabwe was intended to gone towards "combating HIV/Aids, TB, malaria, healthcare for mothers and children, and preparing for epidemics".

"We are confident this partnership would have delivered significant benefits for Zimbabwean communities, especially the 1.2 million men, women and children currently receiving HIV treatment through American-funded programmes," the Ambassador added.

However, official spokesman Nick Mangwana said the arrangement was "unfair".

"Our nation was requested to surrender its biological resources and data indefinitely, without any corresponding assurance of benefiting from any medical innovations – such as new medicines or tests – that might result from that provided information," Mangwana explained.

"Put simply, our country would provide the basic resources for medical research with no assurance that the resulting innovations would be available to our people should a future disease outbreak arise."

National Interest and Global Health

He also noted that the US's withdrawal from the World Health Organization (WHO) and its push of bilateral health agreements were upending frameworks already set up through the global organization.

Mangwana gave as an example its Pathogen Access and Benefit Sharing scheme designed to manage future global health emergencies.

"This system is designed to ensure that when a nation provides its information, the benefits – such as vaccines and treatments – are distributed fairly, not commercialised solely by those with the funds to develop them."

Zimbabwe's reservations regarding the US deal "are not meant as anti-American sentiment," Mangwana stressed.

"We welcome further discussions with our US partners on how subsequent collaboration could be structured in a manner that respects the independence and interests of each country."

Health Experts Reaction

The Zimbabwe College of Public Health Physicians (ZCPHP) stated it acknowledged the official position, but urged that negotiations should continue given that a large portion of the country's HIV programmes were funded by external financing.

"In cases where specific concerns exist, including those involving data governance or implementation frameworks, these can often be resolved through detailed discussion and mutually agreed protections," it added.

The halted deal underscores the ongoing debate between receiving crucial foreign assistance and protecting local interests in an ever more interconnected world.

Written by

Tanya Chang

Tech journalist and gadget reviewer with over a decade of experience in the industry.

SpinSpin

Type to search articles.